The Effectiveness of GLP-1 Receptor Agonist Semaglutide on Body Composition in Elderly Obese Diabetic Patients: A Pilot Study.
Yoshinori OzekiTakayuki MasakiAkari KamataShotaro MiyamotoYuichi YoshidaMitsuhiro OkamotoKoro GotohHirotaka ShibataPublished in: Medicines (Basel, Switzerland) (2022)
These results suggest that the GLP1-RA semaglutide effectively reduces body adiposity while maintaining the MM in obese type 2 diabetic patients.
Keyphrases
- body composition
- adipose tissue
- weight loss
- resistance training
- metabolic syndrome
- bone mineral density
- type diabetes
- obese patients
- insulin resistance
- randomized controlled trial
- rheumatoid arthritis
- systematic review
- bariatric surgery
- middle aged
- disease activity
- weight gain
- systemic lupus erythematosus
- systemic sclerosis
- interstitial lung disease
- idiopathic pulmonary fibrosis